Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

is the most common type of multiple sclerosis (MS), making up about 85% of diagnoses. RRMS involves periods known as relapses, during which symptoms worsen, followed by periods of symptom ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Multiple sclerosis (MS) is a progressive autoimmune disease that affects the brain and spinal cord, impacting 2.8 million ...

Earlier studies indicated that COVID infection might cause MS symptoms to worsen, particularly if the symptoms coincide with those associated with long COVID. For this new study, researchers tracked ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in ...

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...